Fabrizio Nelli
11PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jun 26, 2025
Periodic Boosters of COVID-19 Vaccines Do Not Affect the Safety and Efficacy of Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: A Longitudinal Analysis of the Vax-On-Third Study.Agnese Fabbri, Enzo Maria Ruggeri, Antonella Virtuoso
|May 07, 2025
Venous Thromboembolic Risk Does Not Increase After a Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine in Cancer Patients Receiving Active Systemic Therapies: Updated Results from the Vax-On-Third-Profile Study.Fabrizio Nelli, Enzo Maria Ruggeri, Antonella Virtuoso
|Dec 27, 2024
Longitudinal Assessment of FT3 to FT4 Conversion Ratio in Predicting the Efficacy of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small Cell Lung Cancer: A Propensity-Score Matching Analysis of Data from the National Drug Monitoring Agency.Fabrizio Nelli, Enzo Maria Ruggeri, Marta Schirripa
|Jan 26, 2024
Early Changes in LIPI Score Predict Immune-Related Adverse Events: A Propensity Score Matched Analysis in Advanced Non-Small Cell Lung Cancer Patients on Immune Checkpoint Blockade.Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso
|Jan 20, 2024
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study.Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso
|Sep 27, 2023
Effects of Acetaminophen Exposure on Outcomes of Patients Receiving Immune Checkpoint Inhibitors for Advanced Non-Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.Fabrizio Nelli, Antonella Virtuoso, Diana Giannarelli
Pageof 2
